Home › Funds › Nantahala Capital Management, LLC › TNGX

Nantahala Capital Management, LLC position in TNGX

TANGO THERAPEUTICS INC · Health Care

Nantahala Capital Management, LLC reported holding 707,136 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$17.6M, representing 0.81% of its reported portfolio and ranking #44 among its reported holdings. Nantahala Capital Management, LLC has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)707.14K sh
Reported value held$17.64M
Portfolio Weight0.81%
First reportedQ4 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's TNGX position evolved

Nantahala Capital Management, LLC first disclosed a stake in TNGX in Q4 2024 at 2,804,410 shares (US$8.7M). The position peaked in Q4 2025 at 3,572,633 shares, worth US$31.7M. Across 8 filings, Nantahala Capital Management, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 707,136 shares valued at US$17.6M — an increase of 206,477 shares quarter over quarter.. Notable position changes include a 97% increase in Q4 2025 (shares rose 136% over the following quarter), a 65% trim in Q1 2026 (shares rose 49% over the following quarter), a 60% trim in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.80M $8.67M New
Q1 2025 2.99M $4.09M Add
Q2 2025 3.44M $17.61M Add
Q3 2025 1.81M $15.20M Reduce
Q4 2025 3.57M $31.65M Add
Q1 2026 1.25M $26.16M Reduce
Q2 2026 500.66K $15.65M Reduce
Q3 2026 707.14K $17.64M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 71 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Nantahala Capital Management, LLC held TNGX?

Nantahala Capital Management, LLC has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Nantahala Capital Management, LLC's current position in TNGX?

As of Q3 2026, Nantahala Capital Management, LLC holds 707.14K shares of TNGX (TANGO THERAPEUTICS INC), valued at $17.64M, representing 0.81% of its reported portfolio and ranking #44.

Has Nantahala Capital Management, LLC been buying or selling TNGX?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in TNGX. The position peaked in Q4 2025 at 3.57M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.